166 related articles for article (PubMed ID: 27771051)
1. Enhanced Oral Delivery of Bisphosphonate by Novel Absorption Enhancers: Improvement of Intestinal Absorption of Alendronate by N-Acyl Amino Acids and N-Acyl Taurates and Their Absorption-Enhancing Mechanisms.
Nakaya Y; Takaya M; Hinatsu Y; Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2016 Dec; 105(12):3680-3690. PubMed ID: 27771051
[TBL] [Abstract][Full Text] [Related]
2. Enhanced oral delivery of alendronate by sucrose fatty acids esters in rats and their absorption-enhancing mechanisms.
Alama T; Katayama H; Hirai S; Ono S; Kajiyama A; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2016 Dec; 515(1-2):476-489. PubMed ID: 27793710
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the Solubility and Intestinal Absorption of Curcumin by N-Acyl Taurates and Elucidation of the Absorption-Enhancing Mechanisms.
Li X; Kawamura A; Sato Y; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2017; 40(12):2175-2182. PubMed ID: 29199240
[TBL] [Abstract][Full Text] [Related]
4. A peptide prodrug approach for improving bisphosphonate oral absorption.
Ezra A; Hoffman A; Breuer E; Alferiev IS; Mönkkönen J; El Hanany-Rozen N; Weiss G; Stepensky D; Gati I; Cohen H; Törmälehto S; Amidon GL; Golomb G
J Med Chem; 2000 Oct; 43(20):3641-52. PubMed ID: 11020278
[TBL] [Abstract][Full Text] [Related]
5. Absorption-Enhancing Mechanisms of Capryol 90, a Novel Absorption Enhancer, for Improving the Intestinal Absorption of Poorly Absorbed Drugs: Contributions to Trans- or Para-Cellular Pathways.
Ukai H; Imanishi A; Kaneda A; Kimura E; Koyama M; Morishita M; Katsumi H; Yamamoto A
Pharm Res; 2020 Nov; 37(12):248. PubMed ID: 33230672
[TBL] [Abstract][Full Text] [Related]
6. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
7. Potential of single cationic amino acid molecule "Arginine" for stimulating oral absorption of insulin.
Kamei N; Khafagy ES; Hirose J; Takeda-Morishita M
Int J Pharm; 2017 Apr; 521(1-2):176-183. PubMed ID: 28223245
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
Cohen H; Alferiev IS; Mönkkönen J; Seibel MJ; Pinto T; Ezra A; Solomon V; Stepensky D; Sagi H; Ornoy A; Patlas N; Hägele G; Hoffman A; Breuer E; Golomb G
Pharm Res; 1999 Sep; 16(9):1399-406. PubMed ID: 10496656
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate prodrugs.
Vepsäläinen JJ
Curr Med Chem; 2002 Jun; 9(12):1201-8. PubMed ID: 12052172
[TBL] [Abstract][Full Text] [Related]
10. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules.
Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A
Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050
[TBL] [Abstract][Full Text] [Related]
11. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
Zhang H; Huang X; Zhang Y; Gao Y
Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
[TBL] [Abstract][Full Text] [Related]
12. Administration routes and delivery systems of bisphosphonates for the treatment of bone resorption.
Ezra A; Golomb G
Adv Drug Deliv Rev; 2000 Aug; 42(3):175-95. PubMed ID: 10963835
[TBL] [Abstract][Full Text] [Related]
13. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment.
Meng J; Hu L
J Pharm Pharmacol; 2011 Mar; 63(3):400-8. PubMed ID: 21749388
[TBL] [Abstract][Full Text] [Related]
14. Sodium EDTA enhances intestinal absorption of two bisphosphonates.
Janner M; Mühlbauer RC; Fleisch H
Calcif Tissue Int; 1991 Oct; 49(4):280-3. PubMed ID: 1836974
[TBL] [Abstract][Full Text] [Related]
15. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
16. On the absorption of alendronate in rats.
Lin JH; Chen IW; deLuna FA
J Pharm Sci; 1994 Dec; 83(12):1741-6. PubMed ID: 7891304
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane.
Yamamoto A; Uchiyama T; Nishikawa R; Fujita T; Muranishi S
J Pharm Pharmacol; 1996 Dec; 48(12):1285-9. PubMed ID: 9004192
[TBL] [Abstract][Full Text] [Related]
18. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
19. Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement.
Li X; Uehara S; Sawangrat K; Morishita M; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2018 Jan; 535(1-2):340-349. PubMed ID: 29157961
[TBL] [Abstract][Full Text] [Related]
20. Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity.
Kim JE; Yoon IS; Cho HJ; Kim DH; Choi YH; Kim DD
Int J Pharm; 2014 Apr; 464(1-2):117-26. PubMed ID: 24463005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
